Skip to content

King Pharmaceuticals KG Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

SiriusPoint logo
SiriusPointSPNT
$20M-7.0%
Silvercrest Asset Management Group logo
Silvercrest Asset Management GroupSAMG
$16.15M+8.2%
Lazard logo
LazardLAZ
$402.5M-6.5%
Tiptree Inc. logo
Tiptree Inc.TIPT
Verisk Analytics, Inc. logo
Verisk Analytics, Inc.VRSK
W.R. Berkley logo
W.R. BerkleyWRB

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-71.3%
Enterprise value$184.93M-52.3%
P/E1.2×
P/S1.6×-27.7×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's operating lease ROU assets?
King Pharmaceuticals (KG) reported operating lease ROU assets of $1.97M in Q1 2026.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.